Viewing Study NCT02905032


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-01-01 @ 4:31 PM
Study NCT ID: NCT02905032
Status: COMPLETED
Last Update Posted: 2022-01-25
First Post: 2016-09-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: SDM for Stroke Prevention in Atrial Fibrillation
Sponsor: Mayo Clinic
Organization:

Study Overview

Official Title: Shared Decision Making for Stroke Prevention in Atrial Fibrillation (SDM4Afib): A Randomized Trial
Status: COMPLETED
Status Verified Date: 2021-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SDM4Afib
Brief Summary: The objective of this project is to evaluate a treatment decision aid for patients with atrial fibrillation.
Detailed Description: The goal of this study is to determine the extent to which the Anticoagulation Choice tool promotes shared decision making and its impact on anticoagulation use and adherence versus standard care in patients with nonvalvular atrial fibrillation.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
1R01HL131535 NIH None https://reporter.nih.gov/quic… View